Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 6, 1998, Pages 806-812

  Zhai, Qing Zhu ^a   Ingenito, Alphonse J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antihypertensive drugs; Arterial pressure; Bremazocine; Hippocampus; Kappa opioid agonist; Kappa opioid receptor; Spiradoline; Spontaneously hypertensive rat; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BREMAZOCINE; DRUG VEHICLE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; RECEPTOR SUBTYPE; SODIUM CHLORIDE; SPIRADOLINE; SPIRADOLINE MESILATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; HEART RATE; HIPPOCAMPUS; HYPERTENSION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOMORPHANS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PYRROLIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, OPIOID, KAPPA;

EID: 0345367900     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199806000-00002     Document Type: Article

References (31)

1. Wang JQ, Ingenito AJ. Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation. J Pharmacol Exp Ther 1992;261:678-85.
2. Wang JQ, Ingenito AJ. Cardiovascular responses to intrahippocampal dynorphin A(1-8) in spontaneously hypertensive rats. Eur J Pharmacol 1994;256:57-64.
3. Wang JQ, Ingenito AJ. Comparative effects of intrahippocampal injection of dynorphin A(1-80, (1-13), (1-17), U-50,488H and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Peptides 1994;15:125-32.
4. Wang JQ, Ingenito AJ. Cardiovascular effects of microinjection of dynorphin A(1-8) into the hippocampus in conscious spontaneously hypertensive and normotensive Wistar-Kyoto rats. Clin Exp Hypertens 1994;16:229-43.
5. Li SJ, Wong SC, Ingenito AJ. A low hippocampal dynorphin A (1-8) immunoreactivity in spontaneously hypertensive rats. Neuropeptides 1989;13:197-200.
6. Wang JQ, Li SJ, Ingenito AJ, McGinty JF. A deficit in preprodynorphin mRNA expression in hippocampus of spontaneously hypertensive rats. Mol Brain Res 1994;23:345-8.
7. Privette TH, Wang JQ, Ingenito AJ, Terrian DM. Dentate granule cells as a central cardioregulatory site in the rat. Brain Res 1994;656:295-301.
8. Vonvoightlander PF, Lahti RA, Ludens JH. U-50,488H: a selective and structurally novel non-Mu (kappa) opioid agonist. J Pharmacol Exp Ther 1983;224:7-12.
9. Vonvoightlander PF, Lewis RA. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. J Pharmacol Exp Ther 1988;246:259-62.
10. Zhai QZ, Ingenito AJ. Sustained antihypertensive effects of chronic administration of two kappa opioid agonists in spontaneously hypertensive rats. Am J Ther 1997;4:173-80.
11. Unterwald EM, Knapp C, Zukin RS. Neuroanatomical localization of kappa-1 and kappa-2 opioid receptors in rat and guinea pig brain. Brain Res 1991;562:57-65.
12. Webster JL, Polgar WE, Brant SR, Berzetei-Gurske IP, Toll L. Comparison of kappa-2 opioid receptors in guinea pig brain and guinea pig ileum membranes. Eur J Pharmacol 1993;231:251-8.
13. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic, 1986.
14. Holaday JW. Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol 1983;23:541-94.
15. Feuerstein G, Siren A-L. The opioid system in cardiac and vascular regulation of normal and hypertensive states. Circulation 1987;(suppl I)75:I125-9.
16. Feuerstein G, Faden AI. Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. Life Sci 1982;31:2197-200.
17. Hassan AH, Feuerstein G, Faden AI. Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat. J Neurosci 1984;4:2213-21.
18. Gulati A, Bhargava HN. Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats. Eur J Pharmacol 1988;156:247-57.
19. Ensinger H, Hedler L, Szabo B, Starke K. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors. J Cardiovasc Pharmacol 1986;8:470-5.
20. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endoer Rev 1991;12:118-34.
21. Birch PJ, Rogers H, Hayes AG, et al. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. Br J Pharmacol 1991;103:1819-23.
22. Mackay KB, Kusumoto K, Graham DI, McCulloch J. Effect of kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat. Brain Res 1993;629:10-8.
23. Peters GR, Ward NJ, Antal EG, Lai PY, deMaar EW. Diuretic actions in man of a selective kappa opioid agonist: U-62,066E. J Pharmacol Exp Ther 1987;240:128-31.
24. Rimoy GH, Bhaskar NK, Wright DM, Rubin PC. Mechanism of diuretic action of spiradoline (U-62,066E) - a kappa opioid receptor agonist in the human. Br J Pharmacol 1991;32:611-5.
25. Reece PA, Sedman AJ, Rose S, Wright S, Dawkins R, Rajagopalan R. Diuretic effects, pharmacokinetics and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. J Clin Pharmacol 1994;34:1126-32.
26. Rimoy GH, Wright DM, Bhaskar NK, Rubin PC. The cardiovascular and central nervous system effects in the human of U-62066E. Eur J Clin Pharmacol 1994;46:203-7.
27. Kraft K, Diehl J, Egen A, Stumpe K-O. Chronic kappa-opioid receptor antagonism delays the rise in blood pressure in spontaneously hypertensive rats. Eur J Pharmacol 1991;200:219-26.
28. Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors. Science 1986;233:774-6.
29. Peters G, Gaylor S. Human central nervous system effects of a selective kappa opioid agonist. Clin Pharmacol Ther 1989;45:130.
30. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE. Central hypotensive effects of the alpha-2a-adrenergic receptor subtype. Science 1996;273:801-3.
31. Link RE, Desai K, Hein L, et al. Cardiovascular regulation in mice lacking alpha-2 adrenergic receptor subtypes b and c. Science 1996;273:803-5.